Literature DB >> 24182672

Pathomorphologic findings in left ventricular hypertrabeculation/noncompaction of adults in relation to neuromuscular disorders.

Daniel Gerger1, Claudia Stöllberger, Martin Grassberger, Birgit Gerecke, Horst Andresen, Rolf Engberding, Josef Finsterer.   

Abstract

BACKGROUND: Aim of this study was to assess pathomorphologic findings (PATHO) in patients with echocardiographically (ECHO) diagnosed left ventricular hypertrabeculation/noncompaction.
METHODS: ECHO-criteria for LVHT were: >3 trabeculations, moving synchronously with the compacted myocardium, and forming the noncompacted part of a two-layered myocardium. At autopsy, the hearts were investigated according to the pathologists' preferences.
RESULTS: Twelve patients (2 females, age 27-81 years) were included. Seven suffered from neuromuscular disorders, 5 patients were not investigated neurologically. The specimens were acquired after explantation during heart transplantation (n=1), death due to heart failure (n=6), sudden death (n=2), pneumonia (n=2) and stroke (n=1). Eight hearts were investigated without fixation and 4 after formaldehyde fixation. The hearts were opened along the long-axis, in 3 hearts additional short-axis cuts were carried out. At PATHO the trabecular meshwork was better visible in the formaldehyde-fixed hearts than in the fresh hearts. Differentiation from papillary muscles was easier on the long-axis cuts, whereas the two-layered structure was better visible on short-axis cuts. The trabecular pattern was similar in patients with neuromuscular disorders and those who did not undergo neurologic investigation. Subendocardial fibrosis was found in each case. Due to the complex three-dimensional geometry, it was impossible to count the number of trabeculations.
CONCLUSION: Formaldehyde-fixation should be performed when comparing ECHO with PATHO findings in LVHT. Long-axis as well as short-axis cuts should be carried out in order to assess the course of trabeculations and the extent of the two-layered structure. Subendocardial fibrosis in LVHT deserves further research.
© 2013.

Entities:  

Keywords:  Autopsy; Cardiomyopathy; Muscular dystrophy; Myopathy; Noncompaction; Pathology

Mesh:

Year:  2013        PMID: 24182672     DOI: 10.1016/j.ijcard.2013.08.138

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Fetal Ventricular Hypertrabeculation/Noncompaction: Clinical Presentation, Genetics, Associated Cardiac and Extracardiac Abnormalities and Outcome.

Authors:  Claudia Stöllberger; Christian Wegner; Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2015-05-27       Impact factor: 1.655

2.  Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity.

Authors:  Claudia Stollberger; Josef Finsterer
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

3.  Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy.

Authors:  Caroline Choquet; Thi Hong Minh Nguyen; Pierre Sicard; Emeline Buttigieg; Thi Thom Tran; Frank Kober; Isabelle Varlet; Rachel Sturny; Mauro W Costa; Richard P Harvey; Catherine Nguyen; Pascal Rihet; Sylvain Richard; Monique Bernard; Robert G Kelly; Nathalie Lalevée; Lucile Miquerol
Journal:  PLoS Genet       Date:  2018-07-06       Impact factor: 5.917

4.  Reinforce work-up for myopathy in Takotsubo syndrome.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Int J Cardiol       Date:  2014-08-12       Impact factor: 4.164

Review 5.  Left ventricular noncompaction: a disorder with genotypic and phenotypic heterogeneity-a narrative review.

Authors:  Keiichi Hirono; Fukiko Ichida
Journal:  Cardiovasc Diagn Ther       Date:  2022-08

6.  Higher spatial resolution improves the interpretation of the extent of ventricular trabeculation.

Authors:  Hanne C E Riekerk; Bram F Coolen; Gustav J Strijkers; Allard C van der Wal; Steffen E Petersen; Mary N Sheppard; Roelof-Jan Oostra; Vincent M Christoffels; Bjarke Jensen
Journal:  J Anat       Date:  2021-09-26       Impact factor: 2.610

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.